US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

710.58

+24.843.62%

Number of Gainers:84

Number of Losers:59

Number of Flat:11

PE:- -

High:710.84

Open:685.68

Low:683.13

Close:685.75

Volume:327.91M

Turnover:10.34B

Market Cap:495.36B

Float Cap:376.11B

Loading ...

Market Chatter: Robinhood Plans to Accelerate Debuts for Publicly Traded Closed-end Funds

MT Newswires Live

Analysts Offer Insights on Technology Companies: Riskified (RSKD) and Creative Realities (CREX)

Sector Update: Financial Stocks Advance Thursday Afternoon

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

Applovin Corp Stock (APP) Moved Up by 3.05% on Aug 13: Key Drivers Unveiled

Citi Remains a Hold on Sight Sciences (SGHT)

Eco Wave Power Global (WAVE) Receives a Buy from Maxim Group

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

AppLovin's Q2 Challenges Tied to Model Improvement Timing, RBC Says

MT Newswires Live

Enliven Therapeutics (ELVN) Gets a Buy from Stifel Nicolaus

Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says

MT Newswires Live

Logistic Properties of Americas Posts Investor Fact Sheet on Latin America Cross-Border Logistics Platform

Blend Integrates Prove Pre-Fill for Digital Account Opening at Banks, Credit Unions

Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021

Analyst Reiterates Buy on Sera Prognostics, Citing Expanding Payer Coverage and Large Long‑Term Market Opportunity

Phil Nadeau Initiates Buy on Century Therapeutics, Citing Promising T1D Program, Advancing Pipeline, and Strong Cash Runway

Digital Brands Group Signals Imminent Financial Turnaround

Femasys Inc : Maxim Group Adjusts Target Price to $10 from $30 to Reflect 1-for-20 Reverse Stock Split

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)

Candel Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=38"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":710.5842,"timestamp":1787687999999,"preClose":685.7458,"halted":0,"volume":327910046,"delay":0,"changeRate":0.036221,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":24.83844,"latestTime":"08-25 16:00:00 EDT","open":685.6775,"high":710.84143,"low":683.1322,"amount":10340864745.173748,"amplitude":0.040407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.025441,"increases":84,"decrements":59,"flats":8,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":710.84143,"amplitude":0.040407,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":710.5842,"volume":327910046,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.025441,"peRate":156.391987,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375,"timestamp":1787687999999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":84,"down":59,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:38,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659617321","title":"Market Chatter: Robinhood Plans to Accelerate Debuts for Publicly Traded Closed-end Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2659617321","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659617321?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:35","pubTimestamp":1786646114,"startTime":"0","endTime":"0","summary":"Robinhood Markets  plans to accelerate the pace of debuts for its publicly traded closed-end funds after its first two attempts to make private firms more accessible to its retail customers, Bloomberg reported Thursday, citing an interview with Robinhood chief financial officer Shiv Verma.Robinhood's first fund, with stakes in large private technology companies, debuted in March and is followed by a second fund set to begin trading Thursday, focusing on early stage firms coming out of the startup incubator, Y Combinator, according to the report.Robinhood Markets did not immediately respond to a request for comment by MT Newswires.Price: 98.48, Change: +3.57, Percent Change: +3.76","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOOD","LU1861558580.USD","HOOX","HOOI","BK4539","HOYY","BPAY","HOOZ","HODU","ROBN","FINX","HOOY","HOII","BK4547","CRPT","IAI","BLCK","LU1861559042.SGD","BK4127","HOOW","HOOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659648351","title":"Analysts Offer Insights on Technology Companies: Riskified (RSKD) and Creative Realities (CREX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659648351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659648351?lang=en_us&edition=fundamental","pubTime":"2026-08-14 02:30","pubTimestamp":1786645810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Riskified (RSKD) and Creative Realities (CREX) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-riskified-rskd-and-creative-realities-crex-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-riskified-rskd-and-creative-realities-crex-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CREX","ARTY","TECS","BK4023","RSKD","BK4539","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169412","title":"Sector Update: Financial Stocks Advance Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169412","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659169412?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:29","pubTimestamp":1786642179,"startTime":"0","endTime":"0","summary":"Financial stocks were slightly higher in Thursday afternoon trading, with the NYSE Financial Index up 0.2% and the State Street Financial Select Sector SPDR ETF (XLF) fractionally higher.The Philadelp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4551","LU2360107671.USD","BITQ","ARX","BLCK","COIG","BK4173","CONL","XLRE","CRPT","LU1861558580.USD","FIAT","IBLC","BK4600","BK4588","LU1861217088.USD","BK4595","BK4596","CONY","XLF","LU1861559042.SGD","PSQH","DAPP","BK4585","BK4112","COIN","FDIG","COII","LU1861220207.SGD","COIW","BK4516","BK4554","BKCH","COIA","CONI","BK4077","COIO","COYY","BK4539","FINX","CONX","BK4535","ICOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659691971","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659691971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659691971?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:20","pubTimestamp":1786641612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-candel-therapeutics-cadl-lensar-lnsr-and-pyxis-oncology-pyxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4082","BK4588","XLV","BK4139","LABU","CADL","LU0128526141.USD","XBI","BK4581","BK4137","LNSR","HCSG","PYXS","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659716944","title":"Applovin Corp Stock (APP) Moved Up by 3.05% on Aug 13: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2659716944","media":"TradingKey","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659716944?lang=en_us&edition=fundamental","pubTime":"2026-08-14 01:15","pubTimestamp":1786641329,"startTime":"0","endTime":"0","summary":"• AppLovin shares rebounded via dip-buying and short covering following a post-earnings pullback.\n• Management attributed AXON recommendation engine slowdowns to deployment timing rather than structural headwinds.\n• Technical indicators show an RSI of 26.600 and a Williams %R oversold condition.","market":"other","thumbnail":"https://resource.tradingkey.com/uploads/20251024/applovin-00fd0f57ca9840a2956911818360b64d.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/applovin-00fd0f57ca9840a2956911818360b64d.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262103219-market-movers-app-20260813","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2063271972.USD","IE00B19Z9P08.USD","LU1861215975.USD","BK4613","APPX","XDAT","LU2087625088.SGD","BK4539","BK4023","IE00B894F039.SGD","LU1861220033.SGD","LU2360107168.USD","BK4608","CLOD","IE00B19Z9Z06.USD","LU0056508442.USD","LU2250418816.HKD","LU0353189680.USD","LU2290526834.HKD","APP","LU0154236417.USD","IE00BZ9MQY76.HKD","LU1852331112.SGD","LU2360106780.USD","BK4009","LU0353189763.USD","BK4588","LU0097036916.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166417","title":"Citi Remains a Hold on Sight Sciences (SGHT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166417?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:15","pubTimestamp":1786637757,"startTime":"0","endTime":"0","summary":"Citi analyst Joanne Wuensch maintained a Hold rating on Sight Sciences today and set a price target of $8.00. According to TipRanks, Wuensch is a 4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sight-sciences-sght-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sight-sciences-sght-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGHT","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663701","title":"Eco Wave Power Global (WAVE) Receives a Buy from Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663701?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:55","pubTimestamp":1786636531,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Tate Sullivan from Maxim Group maintained a Buy rating on Eco Wave Power Global, with a price target of $15.00. Acc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/eco-wave-power-global-wave-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/eco-wave-power-global-wave-receives-a-buy-from-maxim-group-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4133","BK4539","WAVE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659663411","title":"Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659663411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659663411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:46","pubTimestamp":1786635988,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals today and set a price target of $4.00. Meacham covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-acumen-pharmaceuticals-abos-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","XLV","ABOS","LABU","XBI","BK4581","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659816575","title":"AppLovin's Q2 Challenges Tied to Model Improvement Timing, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659816575","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659816575?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:42","pubTimestamp":1786635763,"startTime":"0","endTime":"0","summary":"AppLovin's  Q2 challenges were largely related to the timing of a major \"model improvement\" rather than significant changes in demand or the competitive environment, RBC Capital Markets said in a note Thursday.The company's management said a \"sizable\" architectural model improvement was pushed from Q2 into Q3, with the company choosing not to accelerate the rollout at the expense of longer-term benefits. The improvement expands the parameters the model can ingest and is expected to allow AppLovin to make more complete use of its existing data.The investment firm said current Q3 guidance includes the benefit from the model improvement implemented early in the quarter but does not assume an \"incremental inflection.\"AppLovin's management also continues to see a long growth \"runway\" in gaming, though stronger growth over the next three to five years will require a larger contribution from consumer and e-commerce, according to the report.RBC maintained its outperform rating and $575 price t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2250418816.HKD","LU2290526834.HKD","LU2360107168.USD","BK4608","APP","LU0353189763.USD","BK4009","APPX","LU1861220033.SGD","BK4023","LU0097036916.USD","IE00B894F039.SGD","LU2063271972.USD","LU1852331112.SGD","LU0353189680.USD","BK4539","LU2087625088.SGD","CLOD","IE00BZ9MQY76.HKD","XDAT","LU0056508442.USD","LU0154236417.USD","LU1861215975.USD","LU2360106780.USD","IE00B19Z9P08.USD","BK4588","BK4585","IE00B19Z9Z06.USD","BK4613"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165205","title":"Enliven Therapeutics (ELVN) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165205","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165205?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:36","pubTimestamp":1786635368,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Dara Azar reiterated a Buy rating on Enliven Therapeutics today and set a price target of $82.00. According to TipRanks, Az...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/enliven-therapeutics-elvn-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/enliven-therapeutics-elvn-gets-a-buy-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4139","BK4007","BK4539","ELVN","SF","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165487","title":"Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165487","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165487?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:33","pubTimestamp":1786635209,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) remains attractive given its undemanding valuation and differentiated clinical strategy, RBC Capital Markets said in a note emailed Thursday.On the large B-cell lymphoma f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","LENZ","BK4539","ALLO","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165121","title":"Logistic Properties of Americas Posts Investor Fact Sheet on Latin America Cross-Border Logistics Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165121?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:32","pubTimestamp":1786635152,"startTime":"0","endTime":"0","summary":"Logistic Properties of Americas posts investor fact sheet on Latin America cross-border logistics platformLogistic Properties of the Americas highlighted 2Q26 year-on-year growth of 25.6% in total revenue, 27% in NOI.Adjusted EBITDA rose 48.6%, operating GLA increased 9.7%.Stabilized occupancy was 100%, with 76.7% of leases denominated in US dollars.Total gross leasable area was 6 million square feet across Costa Rica, Colombia, Peru, Mexico.Net debt to investment properties was 48%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Logistic Properties of The Americas published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1qyBKz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4539","LPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163717","title":"Blend Integrates Prove Pre-Fill for Digital Account Opening at Banks, Credit Unions","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163717","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163717?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:00","pubTimestamp":1786633225,"startTime":"0","endTime":"0","summary":"Blend integrates Prove Pre-Fill for digital account opening at banks, credit unionsBlend Labs integrated Prove’s Pre-Fill identity verification into its digital origination platform for banks, credit ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLbhrPG2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4023","BLND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659638163","title":"Aveanna Healthcare up over 17%, on Track for Highest Close Since July 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2659638163","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659638163?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:41","pubTimestamp":1786632060,"startTime":"0","endTime":"0","summary":"Aveanna Healthcare Holdings Inc  is currently at $10.64, up $1.59 or 17.51%--Would be highest close since July 23, 2021, when it closed at $10.84--On pace for largest percent increase since Aug. 7, 2025, when it rose 49.36%--Currently up two consecutive days; up 18.83% over this period--Best two day stretch since the two days ending Aug. 8, 2025, when it rose 57.84%--Up 13.26% month-to-date--Up 30.17% year-to-date--Down 17.49% from its all-time closing high of $12.89 on June 14, 2021--Up 47.71% from 52 weeks ago , when it closed at $7.20--Would be a new 52-week closing high--Up 70.98% from its 52-week closing low of $6.22 on April 10, 2026--Traded as high as $10.80; highest intraday level since July 26, 2021, when it hit $10.99--Up 19.34% at today's intraday high; largest intraday percent increase since Aug. 7, 2025, when it rose as much as 59.38%All data as of 10:38:37 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4581","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4137","LU0128526141.USD","BK4539","AVAH","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163986","title":"Analyst Reiterates Buy on Sera Prognostics, Citing Expanding Payer Coverage and Large Long‑Term Market Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163986","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163986?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:36","pubTimestamp":1786631819,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Daniel Brennan has maintained their bullish stance on SERA stock, giving a Buy rating today. Daniel Brennan has given his Buy rati...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-sera-prognostics-citing-expanding-payer-coverage-and-large-longterm-market-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-sera-prognostics-citing-expanding-payer-coverage-and-large-longterm-market-opportunity-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SERA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163663","title":"Phil Nadeau Initiates Buy on Century Therapeutics, Citing Promising T1D Program, Advancing Pipeline, and Strong Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163663","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163663?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:36","pubTimestamp":1786631783,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Phil Nadeau has maintained their bullish stance on IPSC stock, giving a Buy rating today. Phil Nadeau has given his Buy rating due...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/phil-nadeau-initiates-buy-on-century-therapeutics-citing-promising-t1d-program-advancing-pipeline-and-strong-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/phil-nadeau-initiates-buy-on-century-therapeutics-citing-promising-t1d-program-advancing-pipeline-and-strong-cash-runway-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4139","BK4539","IPSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163679","title":"Digital Brands Group Signals Imminent Financial Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163679?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:28","pubTimestamp":1786631307,"startTime":"0","endTime":"0","summary":"Digital Brands Group ( ($DBGI) ) has shared an announcement. On August 12, 2026, Digital Brands Group announced it had achieved a major financial t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/digital-brands-group-signals-imminent-financial-turnaround?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/digital-brands-group-signals-imminent-financial-turnaround?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4122","BK4094","DBGI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168237","title":"Femasys Inc : Maxim Group Adjusts Target Price to $10 from $30 to Reflect 1-for-20 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168237?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:23","pubTimestamp":1786630998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A1AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","FEMY","BK4539","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659168244","title":"Analysts Offer Insights on Healthcare Companies: Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659168244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659168244?lang=en_us&edition=fundamental","pubTime":"2026-08-13 22:10","pubTimestamp":1786630208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Connect Biopharma Holdings (CNTB) and Biomea Fusion ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-connect-biopharma-holdings-cntb-and-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","BMEA","XLV","BK4139","LABU","LU0128526141.USD","XBI","BK4581","BK4137","CNTB","HCSG","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659059150","title":"Candel Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659059150","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659059150?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:59","pubTimestamp":1786629541,"startTime":"0","endTime":"0","summary":"Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryCandel Therapeutics IncCADL.OQreported a quarterly adjusted loss of 52 cents per share for the quarter ended Jun","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL8N44A1GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","CADL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":52,"pageCount":38,"totalSize":1025,"code":"91000000","status":"200"}]}}